Showing results (21-30 of 88) with videos related to
Sort By:
Pageof 9
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 27, 2019
Does attendance at the ECTRIMS congress impact on therapeutic decisions in multiple sclerosis care?Gustavo Saposnik, Jorge Maurino, Angel P Sempere, et al.Annals of General Psychiatry|March 15, 2011
Validation of a specific measure to assess health-related quality of life in patients with schizophrenia and bipolar disorder: the 'Tolerability and quality of life' (TOOL) questionnaireAngel L Montejo, Javier Correas Lauffer, Jesús Cuervo, et al.Frontiers in Neurology|November 5, 2025
Predictive regression models for cognitive impairment, dementia, and Alzheimer's disease using real-world electronic health recordsRaquel Yubero, Rocío García-Cobos, Elena García-Arcelay, et al.JAMA Network Open|July 18, 2019
Comparison of Physician Therapeutic Inertia for Management of Patients With Multiple Sclerosis in Canada, Argentina, Chile, and SpainNoora Almusalam, Jiwon Oh, Maria Terzaghi, et al.BMJ Open|March 10, 2017
Conjoint analysis to understand preferences of patients with multiple sclerosis for disease-modifying therapy attributes in Spain: a cross-sectional observational studyRafael Arroyo, Angel P Sempere, Elena Ruiz-Beato, et al.International Journal of MS Care|November 5, 2019
Assessing Stigma in Multiple Sclerosis: Psychometric Properties of the Eight-Item Stigma Scale for Chronic Illness (SSCI-8)Javier Ballesteros, María L Martínez-Ginés, Jose M García-Domínguez, et al.Patient Preference and Adherence|June 16, 2017
Using a multidimensional unfolding approach to assess multiple sclerosis patient preferences for disease-modifying therapy: a pilot studyAngel Perez Sempere, Vanesa Vera-Lopez, Juana Gimenez-Martinez, et al.Multiple Sclerosis and Related Disorders|December 18, 2019
Factors associated with therapeutic inertia among pharmacists caring for people with multiple sclerosisMaria A Terzaghi, Cedrik Ruiz, Iciar Martínez-López, et al.Frontiers in Neurology|March 17, 2017
Decision-making in Multiple Sclerosis: The Role of Aversion to Ambiguity for Therapeutic Inertia among Neurologists (DIScUTIR MS)Gustavo Saposnik, Angel P Sempere, Daniel Prefasi, et al.Neurology and Therapy|February 26, 2026
Management of Duchenne Muscular Dystrophy in Clinical Practice: A Survey-Based Study in SpainCarlos Ortez, María Branas-Pampillón, Joaquín Alejandro Fernandez, et al.Pageof 9